| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KRT10 ABI1 MYO5A SYNE1 KTN1 SPTBN2 NUMA1 RELA MAST2 SPTBN5 CCDC88A DST FMN2 PPP1R18 PLEC PLEKHH2 CROCC PALLD GOLGA2 KIFC1 CFAP157 NIN | 1.79e-06 | 1099 | 128 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.55e-06 | 5 | 128 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | actin binding | MYO5A SYNE1 SPTBN2 SPTBN5 CCDC88A DST FMN2 PPP1R18 PLEC PLEKHH2 CROCC PALLD | 6.06e-05 | 479 | 128 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | microtubule binding | 1.68e-04 | 308 | 128 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 4.27e-04 | 55 | 128 | 4 | GO:0001046 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 5.34e-04 | 25 | 128 | 3 | GO:0000979 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL5A1 COL6A3 KRT10 KRT12 DSP SPTBN2 NUMA1 COL5A3 DST ERVK-19 EIF3A ERVK-25 PLEC BSN CROCC | 5.90e-04 | 891 | 128 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.08e-03 | 320 | 128 | 8 | GO:0001227 | |
| GeneOntologyMolecularFunction | transcription factor binding | SP3 FOXP2 PPP1R13B RELA GTF2A1 SALL1 WIZ MED12L FOXP1 BSN NFAT5 HCFC1 TP53BP2 | 1.11e-03 | 753 | 128 | 13 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.22e-03 | 326 | 128 | 8 | GO:0001217 | |
| GeneOntologyBiologicalProcess | Golgi organization | MYO5A SYNE1 ATL3 GOLGA8R HUWE1 ATP8B2 SPTBN5 GCC2 PDE4DIP GOLGA2 GOLGB1 | 1.03e-08 | 168 | 131 | 11 | GO:0007030 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | NUMA1 RSPH6A CNTLN SPDL1 WDR47 TEKT2 CCDC88A DST GCC2 CEP250 PDE4DIP CFAP58 FMN2 LZTS2 CROCC GOLGA2 KIFC1 CFAP157 NIN | 1.48e-07 | 720 | 131 | 19 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | MYO5A KTN1 NUMA1 RSPH6A CNTLN SPDL1 WDR47 TEKT2 CCDC88A DST GCC2 CEP250 PDE4DIP CFAP58 FMN2 LZTS2 BSN CROCC DNAH6 GOLGA2 KIFC1 CFAP157 NIN | 2.08e-07 | 1058 | 131 | 23 | GO:0007017 |
| GeneOntologyBiologicalProcess | centriole-centriole cohesion | 2.01e-06 | 15 | 131 | 4 | GO:0010457 | |
| GeneOntologyBiologicalProcess | organelle assembly | RPGRIP1 LIMD1 SYNE1 FBF1 SPTBN2 NUMA1 TCIRG1 PUM2 RNF213 RSPH6A TEKT2 CCDC88A CEP250 CFAP58 PLEC LZTS2 CROCC SCLT1 GOLGA2 KIFC1 CFAP157 | 9.84e-06 | 1138 | 131 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL5A1 KRT10 KRT12 ABI1 NCKAP1 MYO5A DSP SPTBN2 NUMA1 COL5A3 WDR47 SPTBN5 CCDC88A PDE4DIP FMN2 PLEC PLEKHH2 GOLGA2 NIN | 9.93e-06 | 957 | 131 | 19 | GO:0097435 |
| GeneOntologyBiologicalProcess | endomembrane system organization | COL5A1 MYO5A SYNE1 ATL3 GOLGA8R HUWE1 ATP8B2 SPTBN5 COLEC12 GCC2 PDE4DIP PLEC TMCC1 GOLGA2 GOLGB1 | 2.45e-05 | 672 | 131 | 15 | GO:0010256 |
| GeneOntologyBiologicalProcess | negative regulation of lung goblet cell differentiation | 4.00e-05 | 2 | 131 | 2 | GO:1901250 | |
| GeneOntologyBiologicalProcess | regulation of lung goblet cell differentiation | 1.20e-04 | 3 | 131 | 2 | GO:1901249 | |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 1.20e-04 | 3 | 131 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | cilium assembly | RPGRIP1 SYNE1 FBF1 RSPH6A TEKT2 CCDC88A CEP250 CFAP58 CROCC SCLT1 CFAP157 | 1.27e-04 | 444 | 131 | 11 | GO:0060271 |
| GeneOntologyBiologicalProcess | skin development | 1.38e-04 | 373 | 131 | 10 | GO:0043588 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 1.49e-04 | 179 | 131 | 7 | GO:0031023 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 1.60e-04 | 17 | 131 | 3 | GO:0003334 | |
| GeneOntologyBiologicalProcess | cilium organization | RPGRIP1 SYNE1 FBF1 RSPH6A TEKT2 CCDC88A CEP250 CFAP58 CROCC SCLT1 CFAP157 | 2.32e-04 | 476 | 131 | 11 | GO:0044782 |
| GeneOntologyBiologicalProcess | microtubule-based movement | MYO5A KTN1 RSPH6A TEKT2 DST CFAP58 FMN2 BSN DNAH6 KIFC1 CFAP157 | 3.13e-04 | 493 | 131 | 11 | GO:0007018 |
| GeneOntologyCellularComponent | supramolecular fiber | COL5A1 COL6A3 KRT10 KRT12 NCKAP1 MYO5A DSP SYNE1 FBF1 NUMA1 COL5A3 WDR47 TEKT2 DST PDE4DIP FMN2 EIF3A PLEC LZTS2 DNAH6 PALLD GOLGA2 KIFC1 NIN | 2.45e-07 | 1179 | 130 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | COL5A1 COL6A3 KRT10 KRT12 NCKAP1 MYO5A DSP SYNE1 FBF1 NUMA1 COL5A3 WDR47 TEKT2 DST PDE4DIP FMN2 EIF3A PLEC LZTS2 DNAH6 PALLD GOLGA2 KIFC1 NIN | 2.77e-07 | 1187 | 130 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT10 KRT12 NCKAP1 MYO5A DSP FBF1 NUMA1 WDR47 TEKT2 DST PDE4DIP FMN2 EIF3A PLEC LZTS2 DNAH6 PALLD GOLGA2 KIFC1 NIN | 7.22e-07 | 899 | 130 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule organizing center | CRACR2A FBF1 NUMA1 CNTLN IQCD SPDL1 TEKT2 CCDC88A CEP250 PDE4DIP MIB1 CFAP58 LRRCC1 LZTS2 CROCC SCLT1 KIFC1 CFAP157 NIN | 4.11e-06 | 919 | 130 | 19 | GO:0005815 |
| GeneOntologyCellularComponent | centriole | 1.24e-05 | 172 | 130 | 8 | GO:0005814 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 2.73e-05 | 10 | 130 | 3 | GO:0097539 | |
| GeneOntologyCellularComponent | spindle pole | 4.36e-05 | 205 | 130 | 8 | GO:0000922 | |
| GeneOntologyCellularComponent | centrosome | FBF1 NUMA1 CNTLN SPDL1 CCDC88A CEP250 PDE4DIP MIB1 CFAP58 LRRCC1 LZTS2 CROCC SCLT1 KIFC1 NIN | 9.00e-05 | 770 | 130 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | cortical microtubule | 1.15e-04 | 3 | 130 | 2 | GO:0055028 | |
| GeneOntologyCellularComponent | cilium | RPGRIP1 EVC2 MYO5A FBF1 RSPH6A IQCD SPTBN5 TEKT2 CCDC88A CEP250 CFAP58 CROCC SCLT1 DNAH6 CFAP157 NIN | 1.46e-04 | 898 | 130 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.57e-04 | 129 | 130 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | cell cortex region | 1.75e-04 | 45 | 130 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | collagen type V trimer | 2.28e-04 | 4 | 130 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 3.79e-04 | 5 | 130 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | cytoplasmic region | 4.27e-04 | 360 | 130 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | microtubule | NUMA1 WDR47 TEKT2 DST PDE4DIP EIF3A LZTS2 DNAH6 GOLGA2 KIFC1 NIN | 5.05e-04 | 533 | 130 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | cell cortex | 5.30e-04 | 371 | 130 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 5.50e-04 | 26 | 130 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | intermediate filament | 5.54e-04 | 227 | 130 | 7 | GO:0005882 | |
| GeneOntologyCellularComponent | lamellipodium | 5.99e-04 | 230 | 130 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | microtubule plus-end | 6.87e-04 | 28 | 130 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | manchette | 6.87e-04 | 28 | 130 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | spindle | 7.35e-04 | 471 | 130 | 10 | GO:0005819 | |
| GeneOntologyCellularComponent | transcription regulator complex | SP3 LIMD1 MED9 POU2F1 RELA TFAP4 GTF2A1 SALL1 ZFHX3 NFAT5 PMF1 | 1.26e-03 | 596 | 130 | 11 | GO:0005667 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.31e-03 | 263 | 130 | 7 | GO:0045111 | |
| GeneOntologyCellularComponent | spectrin | 1.34e-03 | 9 | 130 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | microtubule end | 1.69e-03 | 38 | 130 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | hemidesmosome | 2.03e-03 | 11 | 130 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | collagen trimer | 2.23e-03 | 88 | 130 | 4 | GO:0005581 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 2.42e-03 | 43 | 130 | 3 | GO:0097431 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.43e-03 | 12 | 130 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.43e-03 | 12 | 130 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | SCAR complex | 2.43e-03 | 12 | 130 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | actin cytoskeleton | NCKAP1 MYO5A ITSN1 SPTBN2 SPTBN5 DST FMN2 PLEKHH2 CROCC PALLD | 3.24e-03 | 576 | 130 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.73e-03 | 317 | 130 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | cell leading edge | 4.09e-03 | 500 | 130 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | ciliary rootlet | 4.35e-03 | 16 | 130 | 2 | GO:0035253 | |
| Domain | Spectrin_repeat | 1.07e-11 | 29 | 123 | 8 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 2.59e-11 | 32 | 123 | 8 | IPR018159 | |
| Domain | SPEC | 2.59e-11 | 32 | 123 | 8 | SM00150 | |
| Domain | Spectrin | 6.65e-09 | 23 | 123 | 6 | PF00435 | |
| Domain | Actinin_actin-bd_CS | 3.49e-07 | 23 | 123 | 5 | IPR001589 | |
| Domain | ACTININ_2 | 3.49e-07 | 23 | 123 | 5 | PS00020 | |
| Domain | ACTININ_1 | 3.49e-07 | 23 | 123 | 5 | PS00019 | |
| Domain | FOXP-CC | 1.11e-06 | 4 | 123 | 3 | PF16159 | |
| Domain | FOXP-CC | 1.11e-06 | 4 | 123 | 3 | IPR032354 | |
| Domain | SH3 | ABI1 TRIO ITSN1 PPP1R13B RIMBP3 DST RIMBP3C MCF2L RIMBP3B TP53BP2 | 1.67e-06 | 216 | 123 | 10 | PS50002 |
| Domain | SH3_domain | ABI1 TRIO ITSN1 PPP1R13B RIMBP3 DST RIMBP3C MCF2L RIMBP3B TP53BP2 | 1.97e-06 | 220 | 123 | 10 | IPR001452 |
| Domain | - | 5.49e-06 | 6 | 123 | 3 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 9.57e-06 | 7 | 123 | 3 | IPR001101 | |
| Domain | Plectin | 9.57e-06 | 7 | 123 | 3 | PF00681 | |
| Domain | PLEC | 9.57e-06 | 7 | 123 | 3 | SM00250 | |
| Domain | SH3 | ABI1 TRIO ITSN1 PPP1R13B RIMBP3 RIMBP3C MCF2L RIMBP3B TP53BP2 | 1.32e-05 | 216 | 123 | 9 | SM00326 |
| Domain | CH | 6.88e-05 | 65 | 123 | 5 | SM00033 | |
| Domain | CH | 9.81e-05 | 70 | 123 | 5 | PF00307 | |
| Domain | - | 1.05e-04 | 71 | 123 | 5 | 1.10.418.10 | |
| Domain | CH | 1.20e-04 | 73 | 123 | 5 | PS50021 | |
| Domain | CH-domain | 1.36e-04 | 75 | 123 | 5 | IPR001715 | |
| Domain | GOLGA2L5 | 2.12e-04 | 18 | 123 | 3 | PF15070 | |
| Domain | Golgin_A | 2.12e-04 | 18 | 123 | 3 | IPR024858 | |
| Domain | TEX28/TMCC | 2.56e-04 | 4 | 123 | 2 | IPR019394 | |
| Domain | Tmemb_cc2 | 2.56e-04 | 4 | 123 | 2 | PF10267 | |
| Domain | DUF1908 | 2.56e-04 | 4 | 123 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 2.56e-04 | 4 | 123 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 2.56e-04 | 4 | 123 | 2 | IPR023142 | |
| Domain | - | 2.56e-04 | 4 | 123 | 2 | 1.20.1480.20 | |
| Domain | SH3_2 | 2.60e-04 | 86 | 123 | 5 | IPR011511 | |
| Domain | SH3_2 | 2.60e-04 | 86 | 123 | 5 | PF07653 | |
| Domain | tRNA-bd_arm | 5.10e-04 | 24 | 123 | 3 | IPR010978 | |
| Domain | SH3_1 | 7.63e-04 | 164 | 123 | 6 | PF00018 | |
| Domain | PH_dom-spectrin-type | 1.50e-03 | 9 | 123 | 2 | IPR001605 | |
| Domain | SH3_9 | 1.75e-03 | 78 | 123 | 4 | PF14604 | |
| Domain | ZINC_FINGER_C2H2_1 | SP3 TUT4 SALL3 FOXP2 ZSCAN4 ZNF652 ZBTB24 FOXP4 SALL1 WIZ ZFHX4 FOXP1 ZFHX3 | 1.84e-03 | 777 | 123 | 13 | PS00028 |
| Domain | RHD_dimer | 1.87e-03 | 10 | 123 | 2 | IPR032397 | |
| Domain | RHD_dimer | 1.87e-03 | 10 | 123 | 2 | PF16179 | |
| Domain | NFkB/Dor | 1.87e-03 | 10 | 123 | 2 | IPR000451 | |
| Domain | REL_1 | 1.87e-03 | 10 | 123 | 2 | PS01204 | |
| Domain | RHD_DNA_bind_dom | 1.87e-03 | 10 | 123 | 2 | IPR011539 | |
| Domain | RHD_DNA_bind | 1.87e-03 | 10 | 123 | 2 | PF00554 | |
| Domain | GBP_C | 1.87e-03 | 10 | 123 | 2 | PF02841 | |
| Domain | REL_2 | 1.87e-03 | 10 | 123 | 2 | PS50254 | |
| Domain | - | 1.87e-03 | 10 | 123 | 2 | 2.60.40.340 | |
| Domain | GDS_CDC24_CS | 2.14e-03 | 39 | 123 | 3 | IPR001331 | |
| Domain | Fib_collagen_C | 2.28e-03 | 11 | 123 | 2 | IPR000885 | |
| Domain | G_GB1_RHD3_dom | 2.28e-03 | 11 | 123 | 2 | IPR030386 | |
| Domain | COLFI | 2.28e-03 | 11 | 123 | 2 | PF01410 | |
| Domain | Guanylate-bd_C | 2.28e-03 | 11 | 123 | 2 | IPR003191 | |
| Domain | NC1_FIB | 2.28e-03 | 11 | 123 | 2 | PS51461 | |
| Domain | GBP | 2.28e-03 | 11 | 123 | 2 | PF02263 | |
| Domain | Fib_collagen_C | 2.28e-03 | 11 | 123 | 2 | PD002078 | |
| Domain | Guanylate-bd_N | 2.28e-03 | 11 | 123 | 2 | IPR015894 | |
| Domain | COLFI | 2.28e-03 | 11 | 123 | 2 | SM00038 | |
| Domain | G_GB1_RHD3 | 2.28e-03 | 11 | 123 | 2 | PS51715 | |
| Domain | Collagen | 2.40e-03 | 85 | 123 | 4 | IPR008160 | |
| Domain | Collagen | 2.40e-03 | 85 | 123 | 4 | PF01391 | |
| Domain | PH | 2.46e-03 | 278 | 123 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 2.51e-03 | 279 | 123 | 7 | PS50003 | |
| Domain | PH_domain | 2.56e-03 | 280 | 123 | 7 | IPR001849 | |
| Domain | TF_fork_head_CS_2 | 3.44e-03 | 46 | 123 | 3 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 3.66e-03 | 47 | 123 | 3 | IPR018122 | |
| Domain | PH | 4.11e-03 | 229 | 123 | 6 | PF00169 | |
| Domain | FH | 4.12e-03 | 49 | 123 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 4.12e-03 | 49 | 123 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 4.12e-03 | 49 | 123 | 3 | PS00658 | |
| Domain | Fork_head_dom | 4.12e-03 | 49 | 123 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 4.12e-03 | 49 | 123 | 3 | PS50039 | |
| Domain | Forkhead | 4.12e-03 | 49 | 123 | 3 | PF00250 | |
| Domain | ZINC_FINGER_C2H2_2 | SP3 SALL3 FOXP2 ZSCAN4 ZNF652 ZBTB24 FOXP4 SALL1 WIZ ZFHX4 FOXP1 ZFHX3 | 5.11e-03 | 775 | 123 | 12 | PS50157 |
| Domain | Acyl_Trfase/lysoPLipase | 5.48e-03 | 17 | 123 | 2 | IPR016035 | |
| Domain | Znf_C2H2-like | SP3 SALL3 FOXP2 ZSCAN4 ZNF652 ZBTB24 FOXP4 SALL1 WIZ ZFHX4 FOXP1 ZFHX3 | 6.29e-03 | 796 | 123 | 12 | IPR015880 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.03e-06 | 38 | 90 | 5 | MM14969 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.26e-05 | 61 | 90 | 5 | M27103 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.98e-05 | 63 | 90 | 5 | M11187 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ABI1 NCKAP1 TRIO DSP ITSN1 KTN1 CCDC88A DST MCF2L PHIP GOLGA2 | 1.07e-04 | 439 | 90 | 11 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ABI1 NCKAP1 TRIO DSP ITSN1 KTN1 GOLGA8R CCDC88A DST MCF2L PHIP | 1.33e-04 | 450 | 90 | 11 | M27078 |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 1.44e-04 | 42 | 90 | 4 | M41826 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 1.44e-04 | 42 | 90 | 4 | MM15677 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ABI1 NCKAP1 TRIO DSP ITSN1 KTN1 SPDL1 CCDC88A DST MCF2L PMF1 PHIP GOLGA2 | 2.31e-04 | 649 | 90 | 13 | MM15690 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.65e-04 | 20 | 90 | 3 | MM15061 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.72e-04 | 90 | 90 | 5 | M631 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL5A1 COL6A3 KRT10 KRT12 TRIO MYO5A DSP ITSN1 SPTBN2 COL5A3 SPTBN5 | 3.43e-04 | 502 | 90 | 11 | MM14537 |
| Pubmed | DSP ZSCAN4 HUWE1 HMG20B SPDL1 FASN KMT2D CCDC88A DST SALL1 WIZ ZFHX4 GCC2 FOXP1 ZFHX3 PLEC GOLGB1 TP53BP2 | 3.74e-14 | 418 | 132 | 18 | 34709266 | |
| Pubmed | LIMD1 DSP KTN1 SPTBN2 NUMA1 PPP1R13B HUWE1 SCAF4 SPDL1 FASN KMT2D WIZ PHF3 NFRKB QSER1 LZTS2 PALLD HCFC1 TP53BP2 | 3.40e-13 | 549 | 132 | 19 | 38280479 | |
| Pubmed | ABI1 NCKAP1 FOXP2 TRIO MYO5A SYNE1 ITSN1 KTN1 IQSEC2 SPTBN2 NUMA1 HUWE1 WDR47 CCDC88A DST WIZ PDE4DIP QSER1 BSN GOLGA2 GOLGB1 TP53BP2 LRRC15 | 1.98e-12 | 963 | 132 | 23 | 28671696 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | LIMD1 NCKAP1 TRIO DSP ITSN1 SPTBN2 PPP1R13B RELA CNTLN MAST2 MIPOL1 RIMBP3 CCDC88A DPH5 CEP250 MIB1 LRRCC1 PLEC SCLT1 TP53BP2 NIN | 1.14e-11 | 853 | 132 | 21 | 28718761 |
| Pubmed | Interaction network of human early embryonic transcription factors. | FOXP2 ZSCAN4 POU2F1 TFAP4 HMG20B FOXP4 KMT2D SALL1 WIZ ZFHX4 NFRKB FOXP1 ZFHX3 QSER1 | 8.22e-11 | 351 | 132 | 14 | 38297188 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ABI1 NCKAP1 FOXP2 DSP KTN1 POU2F1 RELA HUWE1 TFAP4 HMG20B WDR47 FOXP4 FASN KMT2D SALL1 WIZ ZFHX4 FOXP1 QSER1 HCFC1 | 9.53e-11 | 857 | 132 | 20 | 25609649 |
| Pubmed | LIMD1 FOXP2 MYO5A NUMA1 PPP1R13B PUM2 POU2F1 RELA TFAP4 SCAF4 HMG20B FOXP4 KMT2D DST SALL1 WIZ ZFHX4 SUPT7L NFRKB FOXP1 ZFHX3 EIF3A QSER1 HCFC1 KIFC1 | 1.54e-10 | 1429 | 132 | 25 | 35140242 | |
| Pubmed | COL6A3 KRT10 SYNE1 RNF213 MAST2 SPTBN5 DST EIF3A PLEC CROCC DNAH6 | 1.59e-10 | 187 | 132 | 11 | 26460568 | |
| Pubmed | DSP SYNE1 ITSN1 KTN1 SPTBN2 PPP1R13B RELA GTF2A1 CCDC88A DST CEP250 EIF3A PLEC GOLGA2 GOLGB1 | 5.90e-10 | 486 | 132 | 15 | 20936779 | |
| Pubmed | MYO5A DSP SYNE1 NUMA1 MAST2 KMT2D DST FAM186A CEP250 PLEC GOLGB1 | 1.71e-09 | 234 | 132 | 11 | 36243803 | |
| Pubmed | SP3 ABI1 NCKAP1 MYO5A SYNE1 ZNF652 KTN1 PUM2 RELA SCAF4 HMG20B DST WIZ PHF3 SUPT7L NFRKB PPP1R18 ZFHX3 EIF3A LZTS2 CROCC TMCC1 GOLGB1 KIFC1 | 2.12e-09 | 1497 | 132 | 24 | 31527615 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ABI1 LRRC57 KTN1 SPTBN2 PPP1R13B FAM171B FASN DST PPP1R18 PLEC LZTS2 HCFC1 GOLGA2 GOLGB1 TP53BP2 | 4.53e-09 | 565 | 132 | 15 | 25468996 |
| Pubmed | KRT10 ABI1 NCKAP1 TRIO MYO5A DSP SYNE1 ITSN1 KTN1 IQSEC2 SPTBN2 WDR47 FASN DST PDE4DIP LRRCC1 PPP1R18 EIF3A PLEC BSN CROCC DNAH6 TP53BP2 | 4.60e-09 | 1431 | 132 | 23 | 37142655 | |
| Pubmed | HMG20B FOXP4 KMT2D WIZ PHF3 SUPT7L NFRKB FOXP1 QSER1 HCFC1 KIFC1 | 7.04e-09 | 268 | 132 | 11 | 33640491 | |
| Pubmed | COL6A3 KRT10 ABI1 TRIO DSP SYNE1 KTN1 MAST2 DST PDE4DIP MED12L EIF3A PLEC PALLD | 7.27e-09 | 497 | 132 | 14 | 23414517 | |
| Pubmed | A2M EVC2 LIMD1 ZSCAN4 ITSN1 PPP1R13B HUWE1 KMT2D DST CEP250 PDE4DIP PLEC LZTS2 GOLGB1 TP53BP2 | 8.26e-09 | 591 | 132 | 15 | 15231748 | |
| Pubmed | TUT4 FOXP2 FBF1 RNF213 FASTKD5 TEP1 MAST2 HMG20B FOXP4 WIZ ZFHX4 SUPT7L NFRKB FMN2 FOXP1 ZFHX3 TRAF3IP3 LZTS2 PHIP NIN | 8.77e-09 | 1116 | 132 | 20 | 31753913 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | COL5A1 TUT4 LIMD1 TRIO MYO5A RNF213 HUWE1 TEP1 TFAP4 MIPOL1 FOXP4 TULP4 GCC2 FOXP1 ZFHX3 QSER1 LZTS2 MCF2L CROCC NFAT5 PMF1 TMCC1 GOLGB1 | 9.65e-09 | 1489 | 132 | 23 | 28611215 |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 14516685 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 5.34e-08 | 3 | 132 | 3 | 19907493 | |
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 5.34e-08 | 3 | 132 | 3 | 25027557 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 28507505 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 25660448 | ||
| Pubmed | KTN1 SPTBN2 RNF213 ATP8B2 SCAF4 TULP4 TMCC2 LRRCC1 EIF3A PLEKHH2 PALLD TMCC1 MAST3 | 5.55e-08 | 493 | 132 | 13 | 15368895 | |
| Pubmed | 6.69e-08 | 28 | 132 | 5 | 29365100 | ||
| Pubmed | LIMD1 ITSN1 PPP1R13B FAM171B GTF2A1 CCDC88A LZTS2 GOLGA2 GOLGB1 TP53BP2 | 7.16e-08 | 263 | 132 | 10 | 34702444 | |
| Pubmed | 9.44e-08 | 146 | 132 | 8 | 21399614 | ||
| Pubmed | TRIO MYO5A DSP SPTBN2 PPP1R13B RNF213 RELA HUWE1 FAM171B KMT2D CCDC88A WIZ MIB1 FMN2 PPP1R18 LZTS2 TP53BP2 NIN | 9.98e-08 | 1049 | 132 | 18 | 27880917 | |
| Pubmed | RPGRIP1 KRT10 KRT12 MYO5A DSP SYNE1 ITSN1 KTN1 FBF1 SPTBN2 NUMA1 MIPOL1 FASN DST FAM186A EIF3A PLEC BSN MCF2L DNAH6 GOLGB1 | 1.24e-07 | 1442 | 132 | 21 | 35575683 | |
| Pubmed | TUT4 TRIO ITSN1 KTN1 PUM2 RNF213 FASTKD5 HUWE1 SPDL1 CCDC88A PHF3 NFRKB QSER1 CROCC HCFC1 | 1.38e-07 | 733 | 132 | 15 | 34672954 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ABI1 LIMD1 NCKAP1 TRIO DSP IQSEC2 MAST2 CCDC88A DST PHF3 FMN2 PLEC PALLD TMCC1 GOLGB1 TP53BP2 | 1.88e-07 | 861 | 132 | 16 | 36931259 |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 14701752 | ||
| Pubmed | Identification and characterization of T reg-like cells in zebrafish. | 2.13e-07 | 4 | 132 | 3 | 29066577 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 2.13e-07 | 4 | 132 | 3 | 19091768 | |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 2.36e-07 | 111 | 132 | 7 | 22558309 | |
| Pubmed | LIMD1 TRIO ITSN1 RELA SCAF4 SPDL1 GTF2A1 DST PHF3 GOLGA2 TP53BP2 KIFC1 | 2.73e-07 | 472 | 132 | 12 | 38943005 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DSP ITSN1 NUMA1 PUM2 POU2F1 HUWE1 TFAP4 SCAF4 FASN KMT2D PHF3 NFRKB PPP1R18 PLEC MN1 | 2.75e-07 | 774 | 132 | 15 | 15302935 |
| Pubmed | TUT4 ABI1 NCKAP1 TRIO MYO5A DSP KTN1 IQSEC2 HUWE1 FAM171B WDR47 CCDC88A TMCC2 PDE4DIP PLEC BSN TMCC1 NDRG4 | 3.34e-07 | 1139 | 132 | 18 | 36417873 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | DSP HUWE1 TFAP4 ZBTB24 SALL1 WIZ ZFHX4 PHF3 ZFHX3 EIF3A NFAT5 HCFC1 KIFC1 | 3.78e-07 | 583 | 132 | 13 | 29844126 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.03e-07 | 120 | 132 | 7 | 31413325 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DSP ITSN1 PPP1R13B CNTLN HUWE1 RIMBP3 CCDC88A SALL1 LZTS2 BSN GOLGA2 GOLGB1 NIN | 4.16e-07 | 588 | 132 | 13 | 38580884 |
| Pubmed | SP3 SALL3 LIMD1 FOXP2 POU2F1 RELA TFAP4 ZBTB24 HMG20B GTF2A1 SALL1 WIZ FOXP1 ZFHX3 NFAT5 | 4.73e-07 | 808 | 132 | 15 | 20412781 | |
| Pubmed | Centlein mediates an interaction between C-Nap1 and Cep68 to maintain centrosome cohesion. | 5.31e-07 | 5 | 132 | 3 | 24554434 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 5.31e-07 | 5 | 132 | 3 | 17855024 | |
| Pubmed | ABI1 NCKAP1 NUMA1 ATP8B2 SCAF4 SPDL1 FASN DST WIZ PHF3 FMN2 GOLGB1 | 5.69e-07 | 506 | 132 | 12 | 30890647 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 6.36e-07 | 256 | 132 | 9 | 33397691 | |
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 17619227 | ||
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 28591638 | ||
| Pubmed | COL5A1 NCKAP1 MYO5A DSP SPTBN2 NUMA1 HUWE1 FASN DST PHF3 PLEC HCFC1 PHIP | 1.34e-06 | 653 | 132 | 13 | 22586326 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 1.36e-06 | 91 | 132 | 6 | 20362542 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.37e-06 | 363 | 132 | 10 | 14691545 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | PGS1 DSP ZNF652 ATL3 RNF213 KMT2D DPH5 PLA2G4B PDE4DIP ERVK-25 PHIP MAST3 | 1.41e-06 | 552 | 132 | 12 | 10737800 |
| Pubmed | 1.45e-06 | 209 | 132 | 8 | 36779422 | ||
| Pubmed | RPGRIP1 ABI1 SALL3 MAST2 MIPOL1 DST ZFHX4 PLA2G4B PDE4DIP TRAF3IP3 PLEC BSN MCF2L CROCC PMF1 NDRG4 | 1.46e-06 | 1006 | 132 | 16 | 15226823 | |
| Pubmed | 1.73e-06 | 214 | 132 | 8 | 22199357 | ||
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 20185820 | ||
| Pubmed | 1.89e-06 | 151 | 132 | 7 | 17043677 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 2.23e-06 | 298 | 132 | 9 | 32353859 | |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 2.36e-06 | 25 | 132 | 4 | 30309841 | |
| Pubmed | 2.51e-06 | 225 | 132 | 8 | 12168954 | ||
| Pubmed | 2.51e-06 | 101 | 132 | 6 | 9872452 | ||
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 2.78e-06 | 26 | 132 | 4 | 30923192 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | LIMD1 DSP KTN1 NUMA1 PUM2 SCAF4 GTF2A1 FASN DST WIZ EIF3A PALLD HCFC1 GOLGB1 TP53BP2 | 2.83e-06 | 934 | 132 | 15 | 33916271 |
| Pubmed | A Conserved Role for Girdin in Basal Body Positioning and Ciliogenesis. | 2.95e-06 | 8 | 132 | 3 | 27623382 | |
| Pubmed | 3.24e-06 | 312 | 132 | 9 | 37120454 | ||
| Pubmed | 3.79e-06 | 407 | 132 | 10 | 12693553 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KRT10 NUMA1 POU2F1 ZBTB24 WIZ PHF3 NFRKB QSER1 PMF1 HCFC1 PHIP KIFC1 | 3.80e-06 | 608 | 132 | 12 | 36089195 |
| Pubmed | ABI1 NCKAP1 KTN1 NUMA1 TCIRG1 FASN TULP4 EIF3A PALLD HCFC1 TP53BP2 KIFC1 | 4.27e-06 | 615 | 132 | 12 | 31048545 | |
| Pubmed | 4.41e-06 | 9 | 132 | 3 | 12482924 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DSP ITSN1 KTN1 IQSEC2 SPTBN2 RNF213 HUWE1 MIPOL1 DST WIZ FMN2 EIF3A GP5 | 4.92e-06 | 736 | 132 | 13 | 29676528 |
| Pubmed | 5.61e-06 | 251 | 132 | 8 | 27507650 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 6.29e-06 | 10 | 132 | 3 | 15345741 | |
| Pubmed | Forkhead Box Protein P1 Is Dispensable for Retina but Essential for Lens Development. | 6.29e-06 | 10 | 132 | 3 | 28384713 | |
| Pubmed | Abi1 is essential for the formation and activation of a WAVE2 signalling complex. | 6.29e-06 | 10 | 132 | 3 | 15048123 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 6.51e-06 | 182 | 132 | 7 | 31067453 | |
| Pubmed | TRIO MYO5A DSP SYNE1 ITSN1 IQSEC2 SPTBN2 HUWE1 WDR47 MIPOL1 DST WIZ PDE4DIP MIB1 LRRCC1 FMN2 PLEC | 7.85e-06 | 1285 | 132 | 17 | 35914814 | |
| Pubmed | LIMD1 NCKAP1 FBF1 PPP1R13B MAST2 MIPOL1 DST LZTS2 TP53BP2 NIN | 8.44e-06 | 446 | 132 | 10 | 24255178 | |
| Pubmed | Foxp1/2/4 regulate endochondral ossification as a suppresser complex. | 8.62e-06 | 11 | 132 | 3 | 25527076 | |
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 12802069 | ||
| Pubmed | 8.80e-06 | 267 | 132 | 8 | 33417871 | ||
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | PGS1 ZNF652 NUMA1 POU2F1 RSPH6A IQCD ATP8B2 CCDC88A BSN MAST3 | 9.12e-06 | 450 | 132 | 10 | 16751776 |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 9.90e-06 | 128 | 132 | 6 | 25332235 | |
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 1.02e-05 | 75 | 132 | 5 | 37298722 | |
| Pubmed | 1.02e-05 | 360 | 132 | 9 | 33111431 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.05e-05 | 361 | 132 | 9 | 26167880 | |
| Pubmed | 1.08e-05 | 130 | 132 | 6 | 12421765 | ||
| Pubmed | 1.17e-05 | 568 | 132 | 11 | 37774976 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.27e-05 | 281 | 132 | 8 | 28706196 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.28e-05 | 202 | 132 | 7 | 33005030 | |
| Pubmed | 1.29e-05 | 134 | 132 | 6 | 19030180 | ||
| Pubmed | 1.30e-05 | 371 | 132 | 9 | 15747579 | ||
| Pubmed | 1.38e-05 | 284 | 132 | 8 | 29459677 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | KRT10 NCKAP1 MYO5A DSP IQSEC2 SPTBN2 FASN PPP1R18 EIF3A PLEC GOLGB1 | 1.42e-05 | 580 | 132 | 11 | 35676659 |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30031127 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8454622 | ||
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 1.43e-05 | 2 | 132 | 2 | 30104377 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15757645 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11231076 | ||
| Pubmed | Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA. | 1.43e-05 | 2 | 132 | 2 | 9199328 | |
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 1.43e-05 | 2 | 132 | 2 | 10873665 | |
| Interaction | GSC interactions | FOXP2 POU2F1 HMG20B FOXP4 KMT2D SALL1 ZFHX4 FOXP1 ZFHX3 QSER1 LRRC15 | 8.16e-12 | 87 | 128 | 11 | int:GSC |
| Interaction | FEV interactions | FOXP2 POU2F1 HMG20B FOXP4 KMT2D SALL1 WIZ ZFHX4 NFRKB FOXP1 ZFHX3 QSER1 KIFC1 | 5.74e-10 | 203 | 128 | 13 | int:FEV |
| Interaction | EGR2 interactions | FOXP2 FOXP4 KMT2D WIZ ZFHX4 PDE4DIP NFRKB FOXP1 ZFHX3 QSER1 HCFC1 GOLGA2 | 9.56e-10 | 171 | 128 | 12 | int:EGR2 |
| Interaction | RCOR1 interactions | DSP NUMA1 HUWE1 HMG20B SPDL1 FASN KMT2D CCDC88A DST SALL1 ZFHX4 GCC2 ZFHX3 PLEC SCLT1 PHIP GOLGA2 TP53BP2 | 2.37e-09 | 494 | 128 | 18 | int:RCOR1 |
| Interaction | PHF21A interactions | SP3 DSP HUWE1 HMG20B KMT2D CCDC88A DST SALL1 ZFHX4 GCC2 ZFHX3 PLEC SCLT1 GOLGB1 TP53BP2 | 4.99e-09 | 343 | 128 | 15 | int:PHF21A |
| Interaction | CRX interactions | SP3 FOXP2 POU2F1 TFAP4 FOXP4 KMT2D SALL1 WIZ ZFHX4 NFRKB FOXP1 ZFHX3 QSER1 | 8.72e-09 | 254 | 128 | 13 | int:CRX |
| Interaction | KDM1A interactions | DSP RELA HUWE1 ZBTB24 HMG20B SPDL1 FASN KMT2D CCDC88A DST WIZ ZFHX4 GCC2 PDE4DIP FOXP1 ZFHX3 PLEC SCLT1 PMF1 GOLGA2 GOLGB1 TP53BP2 NIN | 2.44e-08 | 941 | 128 | 23 | int:KDM1A |
| Interaction | GAN interactions | COL6A3 KRT10 SYNE1 RNF213 RELA MAST2 SPTBN5 DST EIF3A PLEC CROCC DNAH6 | 7.73e-08 | 253 | 128 | 12 | int:GAN |
| Interaction | PCM1 interactions | RPGRIP1 ABI1 DSP FBF1 PPP1R13B CNTLN SPDL1 GCC2 CEP250 MIB1 LRRCC1 SCLT1 GOLGA2 TP53BP2 NIN | 1.12e-07 | 434 | 128 | 15 | int:PCM1 |
| Interaction | FOXP2 interactions | 3.04e-07 | 70 | 128 | 7 | int:FOXP2 | |
| Interaction | SSX2IP interactions | LIMD1 FBF1 NUMA1 PPP1R13B ZBTB24 CEP250 MIB1 LZTS2 SCLT1 GOLGA2 TP53BP2 NIN | 3.14e-07 | 288 | 128 | 12 | int:SSX2IP |
| Interaction | ZFHX4 interactions | 4.07e-07 | 73 | 128 | 7 | int:ZFHX4 | |
| Interaction | GATA2 interactions | 5.80e-07 | 199 | 128 | 10 | int:GATA2 | |
| Interaction | TBR1 interactions | 6.22e-07 | 113 | 128 | 8 | int:TBR1 | |
| Interaction | PRPH interactions | KRT10 KRT12 LIMD1 MYO5A DSP PPP1R13B PPP1R18 PLEC GOLGA2 TP53BP2 | 7.29e-07 | 204 | 128 | 10 | int:PRPH |
| Interaction | NDC80 interactions | PPP1R13B CNTLN PHF3 GCC2 CEP250 MIB1 LRRCC1 SCLT1 PMF1 GOLGA2 TP53BP2 NIN | 7.34e-07 | 312 | 128 | 12 | int:NDC80 |
| Interaction | SOX5 interactions | 9.45e-07 | 162 | 128 | 9 | int:SOX5 | |
| Interaction | TNIK interactions | ABI1 NCKAP1 FOXP2 TRIO MYO5A SYNE1 IQSEC2 SPTBN2 PPP1R13B HUWE1 DST WIZ PDE4DIP | 9.57e-07 | 381 | 128 | 13 | int:TNIK |
| Interaction | MAPRE1 interactions | TRIO KTN1 NUMA1 PPP1R13B SPDL1 CCDC88A DST GCC2 CEP250 PDE4DIP MIB1 EIF3A PLEC TMCC1 NIN | 9.63e-07 | 514 | 128 | 15 | int:MAPRE1 |
| Interaction | CEP135 interactions | LIMD1 FBF1 PPP1R13B CNTLN CCDC88A CEP250 MIB1 LZTS2 GOLGB1 TP53BP2 NIN | 1.33e-06 | 272 | 128 | 11 | int:CEP135 |
| Interaction | LCK interactions | ABI1 TRIO MYO5A DSP SPTBN2 PPP1R13B FAM171B CCDC88A DST GCC2 FMN2 LZTS2 GOLGA2 GOLGB1 | 1.50e-06 | 463 | 128 | 14 | int:LCK |
| Interaction | TLX1 interactions | 1.80e-06 | 175 | 128 | 9 | int:TLX1 | |
| Interaction | TEAD1 interactions | 1.88e-06 | 176 | 128 | 9 | int:TEAD1 | |
| Interaction | KRT19 interactions | KRT10 KRT12 DSP KTN1 PPP1R13B GCC2 PPP1R18 PLEC LZTS2 TP53BP2 NIN | 1.90e-06 | 282 | 128 | 11 | int:KRT19 |
| Interaction | NFIX interactions | 1.92e-06 | 227 | 128 | 10 | int:NFIX | |
| Interaction | DLGAP1 interactions | 2.27e-06 | 180 | 128 | 9 | int:DLGAP1 | |
| Interaction | TSGA10 interactions | 2.83e-06 | 97 | 128 | 7 | int:TSGA10 | |
| Interaction | CEP128 interactions | NCKAP1 DSP FBF1 PPP1R13B MIPOL1 MIB1 LZTS2 SCLT1 PALLD TP53BP2 NIN | 3.13e-06 | 297 | 128 | 11 | int:CEP128 |
| Interaction | PAX6 interactions | POU2F1 TFAP4 HMG20B MIPOL1 KMT2D SALL1 WIZ ZFHX4 NFRKB FOXP1 ZFHX3 QSER1 | 3.86e-06 | 366 | 128 | 12 | int:PAX6 |
| Interaction | VSX1 interactions | 3.88e-06 | 66 | 128 | 6 | int:VSX1 | |
| Interaction | AR interactions | MYO5A DSP NUMA1 RNF213 POU2F1 RELA HUWE1 HMG20B FOXP4 KMT2D WIZ PHF3 SUPT7L NFRKB MED12L FOXP1 ZFHX3 QSER1 HCFC1 KIFC1 | 4.40e-06 | 992 | 128 | 20 | int:AR |
| Interaction | TLE5 interactions | CRACR2A FOXP2 FBF1 POU2F1 RELA ZBTB24 RIMBP3 SNCAIP TMCC2 MED12L ZFHX3 LZTS2 GOLGA2 | 5.02e-06 | 443 | 128 | 13 | int:TLE5 |
| Interaction | H2BC9 interactions | DSP FBF1 NUMA1 ATL3 TEP1 DST ZFHX4 PDE4DIP CROCC DNAH6 PALLD GOLGA2 TP53BP2 | 5.40e-06 | 446 | 128 | 13 | int:H2BC9 |
| Interaction | FOXP1 interactions | FOXP2 IQSEC2 FOXP4 SALL1 ZFHX4 FOXP1 QSER1 NFAT5 PHIP GOLGA2 | 5.60e-06 | 256 | 128 | 10 | int:FOXP1 |
| Interaction | YWHAH interactions | EVC2 ABI1 LIMD1 NCKAP1 TRIO DSP IQSEC2 HUWE1 MAST2 CCDC88A SNCAIP DST PHF3 FMN2 PLEC SUCO PALLD TMCC1 MAST3 TP53BP2 NIN | 5.91e-06 | 1102 | 128 | 21 | int:YWHAH |
| Interaction | FAM184A interactions | 6.47e-06 | 72 | 128 | 6 | int:FAM184A | |
| Interaction | NINL interactions | LIMD1 MYO5A DSP PPP1R13B CNTLN HUWE1 MIPOL1 CEP250 ZFHX3 LZTS2 SCLT1 PALLD TP53BP2 | 7.19e-06 | 458 | 128 | 13 | int:NINL |
| Interaction | FLOT1 interactions | TRIO ITSN1 FBF1 SPTBN2 PPP1R13B TCIRG1 FAM171B CCDC88A DST FMN2 PLEC LZTS2 NIN | 1.06e-05 | 475 | 128 | 13 | int:FLOT1 |
| Interaction | WHAMMP3 interactions | 1.10e-05 | 119 | 128 | 7 | int:WHAMMP3 | |
| Interaction | FBF1 interactions | 1.37e-05 | 171 | 128 | 8 | int:FBF1 | |
| Interaction | SOX7 interactions | 1.38e-05 | 82 | 128 | 6 | int:SOX7 | |
| Interaction | PAX7 interactions | 1.44e-05 | 124 | 128 | 7 | int:PAX7 | |
| Interaction | WWTR1 interactions | LIMD1 KTN1 NUMA1 PPP1R13B SPDL1 KMT2D WIZ PHF3 QSER1 LZTS2 HCFC1 TP53BP2 | 1.62e-05 | 422 | 128 | 12 | int:WWTR1 |
| Interaction | PPP1R13B interactions | 1.69e-05 | 176 | 128 | 8 | int:PPP1R13B | |
| Interaction | PAX2 interactions | 1.69e-05 | 85 | 128 | 6 | int:PAX2 | |
| Interaction | TLX3 interactions | 1.71e-05 | 291 | 128 | 10 | int:TLX3 | |
| Interaction | NIN interactions | ABI1 LIMD1 TRIO PPP1R13B CEP250 MIB1 LRRCC1 SCLT1 PALLD TP53BP2 NIN | 1.87e-05 | 359 | 128 | 11 | int:NIN |
| Interaction | MIB1 interactions | ITSN1 FAM171B FASN CEP250 MIB1 LRRCC1 EIF3A PALLD TP53BP2 NIN | 1.92e-05 | 295 | 128 | 10 | int:MIB1 |
| Interaction | PAX9 interactions | 1.96e-05 | 130 | 128 | 7 | int:PAX9 | |
| Interaction | GFAP interactions | 2.02e-05 | 236 | 128 | 9 | int:GFAP | |
| Interaction | RTP5 interactions | 2.15e-05 | 53 | 128 | 5 | int:RTP5 | |
| Interaction | HDAC1 interactions | SP3 POU2F1 RELA TFAP4 HMG20B SPDL1 FASN KMT2D DST SALL1 WIZ ZFHX4 GCC2 CEP250 ZFHX3 PLEC CROCC HCFC1 GOLGB1 TP53BP2 | 2.22e-05 | 1108 | 128 | 20 | int:HDAC1 |
| Interaction | EIF4ENIF1 interactions | 2.22e-05 | 300 | 128 | 10 | int:EIF4ENIF1 | |
| Interaction | FAM74A4 interactions | 2.43e-05 | 27 | 128 | 4 | int:FAM74A4 | |
| Interaction | RASSF8 interactions | 2.50e-05 | 91 | 128 | 6 | int:RASSF8 | |
| Interaction | ZFPL1 interactions | ABI1 TRIO ITSN1 SPTBN2 PPP1R13B FAM171B CCDC88A DST GCC2 LZTS2 GOLGA2 GOLGB1 | 2.91e-05 | 448 | 128 | 12 | int:ZFPL1 |
| Interaction | NEFM interactions | 2.94e-05 | 190 | 128 | 8 | int:NEFM | |
| Interaction | HNF1B interactions | 2.94e-05 | 190 | 128 | 8 | int:HNF1B | |
| Interaction | MED4 interactions | A2M MED9 ITSN1 PUM2 HUWE1 SCAF4 DST MIB1 MED12L LRRCC1 TP53BP2 NIN | 3.04e-05 | 450 | 128 | 12 | int:MED4 |
| Interaction | ASF1A interactions | 3.09e-05 | 249 | 128 | 9 | int:ASF1A | |
| Interaction | SOX17 interactions | 3.19e-05 | 95 | 128 | 6 | int:SOX17 | |
| Interaction | SOX15 interactions | 3.30e-05 | 141 | 128 | 7 | int:SOX15 | |
| Interaction | NR2F1 interactions | 3.34e-05 | 58 | 128 | 5 | int:NR2F1 | |
| Interaction | CSPP1 interactions | 3.39e-05 | 96 | 128 | 6 | int:CSPP1 | |
| Interaction | ACTC1 interactions | ABI1 NCKAP1 SYNE1 NUMA1 ATP8B2 SCAF4 SPDL1 FASN DST WIZ PHF3 TMCC2 FMN2 PLEC GOLGB1 | 3.51e-05 | 694 | 128 | 15 | int:ACTC1 |
| Interaction | PHIP interactions | 3.80e-05 | 197 | 128 | 8 | int:PHIP | |
| Interaction | FOXP4 interactions | 3.81e-05 | 98 | 128 | 6 | int:FOXP4 | |
| Interaction | RALBP1 interactions | 3.94e-05 | 198 | 128 | 8 | int:RALBP1 | |
| Interaction | GCC1 interactions | 4.03e-05 | 99 | 128 | 6 | int:GCC1 | |
| Interaction | HIC2 interactions | 4.28e-05 | 61 | 128 | 5 | int:HIC2 | |
| Interaction | ATG16L1 interactions | ABI1 CRACR2A MYO5A KTN1 PPP1R13B FAM171B COLEC12 CCDC88A GCC2 CEP250 PPP1R18 EIF3A TRAF3IP3 PLEC LZTS2 PMF1 HCFC1 GOLGA2 GOLGB1 KIFC1 | 4.30e-05 | 1161 | 128 | 20 | int:ATG16L1 |
| Interaction | ITSN2 interactions | 4.31e-05 | 147 | 128 | 7 | int:ITSN2 | |
| Interaction | SALL1 interactions | 4.77e-05 | 102 | 128 | 6 | int:SALL1 | |
| Interaction | TTC23 interactions | 5.58e-05 | 208 | 128 | 8 | int:TTC23 | |
| Interaction | AGAP2 interactions | 5.97e-05 | 210 | 128 | 8 | int:AGAP2 | |
| Interaction | YAP1 interactions | DSP SPTBN2 NUMA1 RELA HUWE1 SCAF4 FASN KMT2D TULP4 PHF3 NFRKB EIF3A PLEC LZTS2 NFAT5 PALLD HCFC1 NDRG4 TP53BP2 | 6.20e-05 | 1095 | 128 | 19 | int:YAP1 |
| Interaction | COL17A1 interactions | 6.21e-05 | 34 | 128 | 4 | int:COL17A1 | |
| Interaction | KCTD13 interactions | KRT10 ABI1 NCKAP1 TRIO MYO5A DSP SYNE1 ITSN1 KTN1 IQSEC2 SPTBN2 WDR47 FASN DST LRRCC1 PPP1R18 EIF3A PLEC BSN CROCC DNAH6 TP53BP2 | 6.36e-05 | 1394 | 128 | 22 | int:KCTD13 |
| Interaction | SOX6 interactions | 6.54e-05 | 157 | 128 | 7 | int:SOX6 | |
| Interaction | RAB2A interactions | LRRC57 MYO5A FBF1 SPTBN2 COLEC12 FASN CCDC88A GCC2 FMN2 SCLT1 GOLGA2 GOLGB1 NIN | 6.65e-05 | 567 | 128 | 13 | int:RAB2A |
| Interaction | BNC2 interactions | 6.83e-05 | 13 | 128 | 3 | int:BNC2 | |
| Interaction | ZFHX3 interactions | 6.92e-05 | 109 | 128 | 6 | int:ZFHX3 | |
| Interaction | PAX8 interactions | 7.66e-05 | 111 | 128 | 6 | int:PAX8 | |
| Interaction | SHANK3 interactions | ABI1 NCKAP1 MYO5A SYNE1 ITSN1 KTN1 IQSEC2 SPTBN2 NUMA1 MIPOL1 ZFHX3 LZTS2 | 7.74e-05 | 496 | 128 | 12 | int:SHANK3 |
| Interaction | DTNBP1 interactions | 7.97e-05 | 162 | 128 | 7 | int:DTNBP1 | |
| Interaction | TNRC6B interactions | 8.08e-05 | 282 | 128 | 9 | int:TNRC6B | |
| Interaction | OCLN interactions | ABI1 TRIO ITSN1 SPTBN2 PPP1R13B FAM171B CCDC88A DST FMN2 LZTS2 GOLGB1 TP53BP2 | 8.36e-05 | 500 | 128 | 12 | int:OCLN |
| Interaction | TOX interactions | 8.66e-05 | 14 | 128 | 3 | int:TOX | |
| Interaction | TEX9 interactions | 8.72e-05 | 37 | 128 | 4 | int:TEX9 | |
| Interaction | IQCE interactions | 8.72e-05 | 37 | 128 | 4 | int:IQCE | |
| Interaction | ERG interactions | 9.08e-05 | 223 | 128 | 8 | int:ERG | |
| Interaction | CEP250 interactions | 9.24e-05 | 287 | 128 | 9 | int:CEP250 | |
| Interaction | CNTROB interactions | 9.29e-05 | 166 | 128 | 7 | int:CNTROB | |
| Interaction | LHX4 interactions | 9.29e-05 | 166 | 128 | 7 | int:LHX4 | |
| Interaction | NFAT5 interactions | 9.69e-05 | 38 | 128 | 4 | int:NFAT5 | |
| Interaction | CIC interactions | DSP HUWE1 TFAP4 ZBTB24 SALL1 WIZ ZFHX4 PHF3 ZFHX3 EIF3A NFAT5 HCFC1 GOLGA2 KIFC1 | 9.75e-05 | 673 | 128 | 14 | int:CIC |
| Interaction | TBXT interactions | 9.79e-05 | 116 | 128 | 6 | int:TBXT | |
| Interaction | FOXP3 interactions | FOXP2 RELA FOXP4 FASN WIZ PHF3 PPP1R18 FOXP1 TRAF3IP3 PLEC NFAT5 | 9.94e-05 | 432 | 128 | 11 | int:FOXP3 |
| Interaction | DYNLL1 interactions | MYO5A DSP KTN1 NUMA1 MAST2 SPDL1 ANKRD20A4P PDE4DIP MIB1 TRAF3IP3 PLEKHH2 GOLGB1 | 1.01e-04 | 510 | 128 | 12 | int:DYNLL1 |
| Interaction | DGCR6 interactions | 1.02e-04 | 73 | 128 | 5 | int:DGCR6 | |
| Cytoband | 1q12 | 2.87e-04 | 9 | 131 | 2 | 1q12 | |
| Cytoband | 22q11.21 | 2.99e-04 | 111 | 131 | 4 | 22q11.21 | |
| Cytoband | 15q21 | 4.37e-04 | 11 | 131 | 2 | 15q21 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.77e-06 | 8 | 81 | 3 | 939 | |
| GeneFamily | Transmembrane and coiled-coil domain containing | 5.93e-05 | 3 | 81 | 2 | 774 | |
| GeneFamily | EF-hand domain containing|Spectrins | 4.10e-04 | 7 | 81 | 2 | 1113 | |
| GeneFamily | Forkhead boxes | 9.40e-04 | 43 | 81 | 3 | 508 | |
| GeneFamily | Collagens | 1.14e-03 | 46 | 81 | 3 | 490 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.00e-03 | 15 | 81 | 2 | 529 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.24e-03 | 66 | 81 | 3 | 722 | |
| GeneFamily | Ankyrin repeat domain containing | 4.63e-03 | 242 | 81 | 5 | 403 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.56e-03 | 25 | 81 | 2 | 775 | |
| GeneFamily | Keratins, type I | 6.95e-03 | 28 | 81 | 2 | 608 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 TUT4 ABI1 NCKAP1 TRIO ITSN1 PUM2 MAST2 DST PHF3 GCC2 ZFHX3 EIF3A SUCO MN1 TMCC1 PHIP TP53BP2 | 2.47e-07 | 856 | 130 | 18 | M4500 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 6.98e-07 | 199 | 130 | 9 | M5893 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.64e-06 | 300 | 130 | 10 | M8702 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SP3 TUT4 ABI1 MYO5A SYNE1 ZNF652 KTN1 NUMA1 PUM2 RNF213 HUWE1 ATP8B2 KMT2D CCDC88A PHF3 PDE4DIP PPP1R18 TRAF3IP3 NFAT5 PHIP MAST3 NIN | 4.12e-06 | 1492 | 130 | 22 | M40023 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TUT4 MYO5A KTN1 TCIRG1 SPDL1 CCDC88A PHF3 GCC2 EIF3A QSER1 SUCO PALLD GOLGB1 NIN | 4.99e-06 | 656 | 130 | 14 | M18979 |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_DN | 1.50e-05 | 290 | 130 | 9 | M13251 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 1.87e-05 | 32 | 130 | 4 | MM1307 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 1.87e-05 | 32 | 130 | 4 | M2334 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.33e-05 | 180 | 130 | 7 | M8239 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 6.49e-05 | 200 | 130 | 7 | M9439 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 6.49e-05 | 200 | 130 | 7 | M8997 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 7.01e-05 | 86 | 130 | 5 | M39247 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 8.77e-05 | 145 | 130 | 6 | M1810 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | SP3 KRT10 SALL3 FOXP2 MYO5A DSP PUM2 HUWE1 GTF2A1 CCDC88A DST SALL1 ZFHX4 TULP4 PDE4DIP MIB1 LRRCC1 FMN2 FOXP1 ZFHX3 | 1.38e-07 | 836 | 128 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TUT4 FOXP2 MYO5A KTN1 PUM2 POU2F1 FASTKD5 CNTLN FAM171B SPDL1 GTF2A1 FASN CCDC88A PHF3 GCC2 LRRCC1 ZFHX3 EIF3A QSER1 CMAHP SCLT1 PHIP KIFC1 | 1.64e-06 | 1257 | 128 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 1.82e-06 | 137 | 128 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | PGS1 TUT4 FOXP2 SYNE1 RNF213 CNTLN SNCAIP ZFHX4 GCC2 EIF3A QSER1 SCLT1 GOLGB1 | 2.17e-06 | 432 | 128 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.23e-06 | 243 | 128 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TUT4 FOXP2 MYO5A KTN1 PUM2 POU2F1 FASTKD5 CNTLN FAM171B SPDL1 GTF2A1 FASN CCDC88A SALL1 PHF3 GCC2 LRRCC1 ZFHX3 EIF3A QSER1 CMAHP SCLT1 PHIP KIFC1 | 5.94e-06 | 1459 | 128 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | FOXP2 DSP HUWE1 FAM171B TEKT2 SNCAIP DST SALL1 ZFHX4 FMN2 FOXP1 NFAT5 | 6.71e-06 | 407 | 128 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | FOXP2 TRIO DSP HUWE1 FAM171B FOXP4 TEKT2 SNCAIP DST SALL1 ZFHX4 PHF3 MIB1 FMN2 FOXP1 NFAT5 MN1 | 7.09e-06 | 806 | 128 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | SP3 MYO5A PUM2 HUWE1 GTF2A1 CCDC88A TULP4 PDE4DIP MIB1 LRRCC1 FOXP1 ZFHX3 | 4.37e-05 | 492 | 128 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 5.90e-05 | 429 | 128 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SP3 TUT4 FOXP2 MYO5A CNTLN FAM171B SPDL1 WDR47 FASN CCDC88A GCC2 LRRCC1 EIF3A QSER1 CMAHP SCLT1 GOLGA2 KIFC1 | 6.71e-05 | 1060 | 128 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.30e-05 | 298 | 128 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | PGS1 TUT4 FOXP2 SYNE1 KTN1 RNF213 POU2F1 CNTLN SNCAIP ZFHX4 GCC2 ZFHX3 EIF3A QSER1 SCLT1 PHIP GOLGB1 | 9.39e-05 | 989 | 128 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | SP3 FOXP2 TRIO DSP FAM171B DST SALL1 ZFHX4 PHF3 MIB1 FMN2 FOXP1 EIF3A SUCO PHIP | 1.05e-04 | 806 | 128 | 15 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | COL6A3 TUT4 OLFML2B SYNE1 RNF213 CNTLN CCDC88A SNCAIP ZFHX4 GCC2 LRRCC1 EIF3A PLEKHH2 SCLT1 | 1.62e-04 | 744 | 128 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | FOXP2 TRIO ITSN1 PUM2 POU2F1 MAST2 HMG20B FOXP4 ZFHX4 FOXP1 ZFHX3 EIF3A PMF1 HCFC1 PHIP | 1.72e-04 | 843 | 128 | 15 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 1.90e-04 | 409 | 128 | 10 | GSM476663_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | TRIO ITSN1 PUM2 POU2F1 HMG20B FOXP4 FOXP1 EIF3A PMF1 HCFC1 PHIP | 2.18e-04 | 498 | 128 | 11 | gudmap_developingGonad_e11.5_testes_k5_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | COL6A3 TUT4 FOXP2 SYNE1 ATL3 HUWE1 FAM171B DST ZFHX4 MIB1 MED12L FMN2 NFAT5 SUCO | 2.36e-04 | 772 | 128 | 14 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_200 | 2.94e-04 | 53 | 128 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | COL6A3 TUT4 FOXP2 TRIO PUM2 CNTLN FAM171B COLEC12 ZFHX4 FOXP1 ZFHX3 NFAT5 SUCO MN1 | 3.02e-04 | 791 | 128 | 14 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200 | 3.16e-04 | 54 | 128 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 4.47e-04 | 25 | 128 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.57e-04 | 375 | 128 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | SP3 TUT4 FOXP2 FASTKD5 CNTLN SPDL1 MIPOL1 GTF2A1 CCDC88A GCC2 LRRCC1 ZFHX3 EIF3A QSER1 CMAHP SCLT1 PHIP KIFC1 | 4.68e-04 | 1241 | 128 | 18 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 4.68e-04 | 163 | 128 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 5.84e-04 | 388 | 128 | 9 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.05e-04 | 311 | 128 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | COL6A3 SP3 TUT4 ABI1 FOXP2 SYNE1 RNF213 SNCAIP ZFHX4 GCC2 ZFHX3 TRAF3IP3 | 6.12e-04 | 655 | 128 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | SP3 FOXP2 MYO5A DSP PUM2 HUWE1 FAM171B CCDC88A DST SALL1 ZFHX4 FMN2 FOXP1 ZFHX3 | 6.18e-04 | 850 | 128 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.50e-09 | 199 | 130 | 9 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.30e-07 | 199 | 130 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.30e-07 | 199 | 130 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-07 | 199 | 130 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.35e-07 | 200 | 130 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-07 | 200 | 130 | 8 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-07 | 200 | 130 | 8 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-07 | 200 | 130 | 8 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-07 | 200 | 130 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-07 | 200 | 130 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 182 | 130 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-06 | 190 | 130 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 192 | 130 | 7 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 192 | 130 | 7 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.62e-06 | 193 | 130 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.68e-06 | 194 | 130 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.80e-06 | 196 | 130 | 7 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.80e-06 | 196 | 130 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.86e-06 | 197 | 130 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-06 | 197 | 130 | 7 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-06 | 197 | 130 | 7 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-06 | 198 | 130 | 7 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.99e-06 | 199 | 130 | 7 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.99e-06 | 199 | 130 | 7 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.99e-06 | 199 | 130 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.99e-06 | 199 | 130 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-06 | 199 | 130 | 7 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.99e-06 | 199 | 130 | 7 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 18-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 1.99e-06 | 199 | 130 | 7 | d65150d2e24c40aa82712e7f034f6772102bd293 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.99e-06 | 199 | 130 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-06 | 200 | 130 | 7 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-06 | 200 | 130 | 7 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-06 | 200 | 130 | 7 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 130 | 7 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | wk_15-18-Mesenchymal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.06e-06 | 200 | 130 | 7 | 4d484260ecbbbd9f820b445bdcc2666f6c464b73 | |
| ToppCell | COVID-19-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 2.06e-06 | 200 | 130 | 7 | a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.25e-06 | 32 | 130 | 4 | ba89b22a5ce8ee9f3099b1fa84721724b94c7759 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.25e-06 | 32 | 130 | 4 | 58b212d4f2955f06a195df0f79ad95a8ff145b83 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.85e-06 | 157 | 130 | 6 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.23e-05 | 174 | 130 | 6 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.40e-05 | 178 | 130 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-05 | 178 | 130 | 6 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.40e-05 | 178 | 130 | 6 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 178 | 130 | 6 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.49e-05 | 180 | 130 | 6 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-05 | 180 | 130 | 6 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.59e-05 | 182 | 130 | 6 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 185 | 130 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.74e-05 | 185 | 130 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.85e-05 | 187 | 130 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.85e-05 | 187 | 130 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.85e-05 | 187 | 130 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.91e-05 | 188 | 130 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-05 | 188 | 130 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 190 | 130 | 6 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.02e-05 | 190 | 130 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.02e-05 | 190 | 130 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 191 | 130 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 191 | 130 | 6 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-05 | 191 | 130 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.15e-05 | 192 | 130 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-05 | 192 | 130 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 193 | 130 | 6 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.21e-05 | 193 | 130 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.21e-05 | 193 | 130 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.21e-05 | 193 | 130 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.21e-05 | 193 | 130 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.21e-05 | 193 | 130 | 6 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.21e-05 | 193 | 130 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.28e-05 | 194 | 130 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.28e-05 | 194 | 130 | 6 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.28e-05 | 194 | 130 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.28e-05 | 194 | 130 | 6 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | d32716a12014522492becbde1088dc1106308490 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-05 | 195 | 130 | 6 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 195 | 130 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 195 | 130 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.34e-05 | 195 | 130 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.34e-05 | 195 | 130 | 6 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.34e-05 | 195 | 130 | 6 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | b913d5df50c88a3a255f516a1aa42419c6701e1e | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.34e-05 | 195 | 130 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 195 | 130 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 15-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 2.41e-05 | 196 | 130 | 6 | b8d95b5f4780e73d16dcc528e70a5496f0314373 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-05 | 196 | 130 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-05 | 196 | 130 | 6 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 196 | 130 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 196 | 130 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-05 | 196 | 130 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.41e-05 | 196 | 130 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.48e-05 | 197 | 130 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.46e-06 | 50 | 85 | 6 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | plakin | 3.43e-07 | 82 | 125 | 7 | CID000018752 | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 1.28e-06 | 194 | 125 | 9 | 4141_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HG-U133A | 1.59e-06 | 199 | 125 | 9 | 337_DN | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.12e-05 | 192 | 125 | 8 | 4340_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.16e-05 | 193 | 125 | 8 | 3262_UP | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | 1.16e-05 | 193 | 125 | 8 | 4488_DN | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.16e-05 | 193 | 125 | 8 | 3627_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 4134_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.30e-05 | 196 | 125 | 8 | 3716_DN | |
| Drug | Dacarbazine [4342-03-4]; Up 200; 22uM; PC3; HT_HG-U133A | 1.35e-05 | 197 | 125 | 8 | 4480_UP | |
| Drug | rapamycin; Down 200; 0.1uM; HL60; HG-U133A | 1.35e-05 | 197 | 125 | 8 | 362_DN | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.40e-05 | 198 | 125 | 8 | 1525_DN | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.40e-05 | 198 | 125 | 8 | 4005_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HG-U133A | 1.40e-05 | 198 | 125 | 8 | 121_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.40e-05 | 198 | 125 | 8 | 2242_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; PC3; HT_HG-U133A | 1.51e-05 | 200 | 125 | 8 | 4076_DN | |
| Drug | toltrazuril | 1.88e-05 | 10 | 125 | 3 | CID000068591 | |
| Drug | PPACK | 3.80e-05 | 113 | 125 | 6 | CID003036757 | |
| Drug | Clorgyline | 4.04e-05 | 168 | 125 | 7 | ctd:D003010 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.22e-05 | 188 | 125 | 7 | 4845_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 8.22e-05 | 188 | 125 | 7 | 4310_DN | |
| Drug | stanolone benzoate | 8.94e-05 | 3 | 125 | 2 | ctd:C040109 | |
| Drug | tetrabromosulfonephthalein | 8.94e-05 | 3 | 125 | 2 | CID000122829 | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 6020_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 5214_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 9.07e-05 | 191 | 125 | 7 | 5200_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; HL60; HT_HG-U133A | 9.37e-05 | 192 | 125 | 7 | 1337_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 9.37e-05 | 192 | 125 | 7 | 6054_DN | |
| Drug | AC1L9LMC | 9.49e-05 | 83 | 125 | 5 | CID000448113 | |
| Drug | W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.00e-04 | 194 | 125 | 7 | 440_UP | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.00e-04 | 194 | 125 | 7 | 4319_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 3812_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 2895_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 3353_DN | |
| Drug | clozapine; Down 200; 10uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 4453_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 4439_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 6273_UP | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 3567_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 125 | 7 | 3416_UP | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; HL60; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 3048_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 2849_DN | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 6545_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 4135_DN | |
| Drug | Ginkgolide A [15291-75-5]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 1324_UP | |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 4847_DN | |
| Drug | Meglumine [6284-40-8]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 5285_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 3748_DN | |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 4963_DN | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 3226_DN | |
| Drug | N-phenylanthranilic acid; Up 200; 10uM; MCF7; HG-U133A | 1.14e-04 | 198 | 125 | 7 | 317_UP | |
| Drug | raloxifene hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A | 1.14e-04 | 198 | 125 | 7 | 202_DN | |
| Drug | Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 4584_UP | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 7428_UP | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 7028_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 4320_UP | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 4472_UP | |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 5326_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 2489_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 7303_DN | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 7421_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 1703_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.21e-04 | 200 | 125 | 7 | 3833_UP | |
| Drug | Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.21e-04 | 200 | 125 | 7 | 4672_DN | |
| Drug | CP-944629 [668990-94-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.21e-04 | 200 | 125 | 7 | 7544_DN | |
| Drug | dimethyl itaconate | 1.78e-04 | 4 | 125 | 2 | CID000069240 | |
| Drug | U-2112 | 2.00e-04 | 21 | 125 | 3 | CID000022641 | |
| Drug | manganese tetroxide | 3.01e-04 | 24 | 125 | 3 | CID000014825 | |
| Drug | AC1L1KMJ | RPGRIP1 COL5A1 COL6A3 SPTBN2 RELA SPTBN5 COLEC12 DST MIB1 PLEC | 3.02e-04 | 476 | 125 | 10 | CID000030956 |
| Drug | DNP19 | 3.78e-04 | 62 | 125 | 4 | CID000446716 | |
| Drug | AC124 | 3.92e-04 | 173 | 125 | 6 | CID000000253 | |
| Drug | vinylene | 4.17e-04 | 245 | 125 | 7 | CID000006326 | |
| Drug | NSC134723 | 4.42e-04 | 6 | 125 | 2 | CID000281830 | |
| Drug | thymol blue | 4.42e-04 | 6 | 125 | 2 | CID000065565 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.43e-04 | 177 | 125 | 6 | 4770_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.84e-04 | 180 | 125 | 6 | 3510_UP | |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 5.92e-04 | 187 | 125 | 6 | 3075_DN | |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 5.92e-04 | 187 | 125 | 6 | 5396_UP | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.92e-04 | 187 | 125 | 6 | 4323_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 6.09e-04 | 188 | 125 | 6 | 1306_UP | |
| Drug | methyltrichlorosilane | 6.17e-04 | 7 | 125 | 2 | CID000006399 | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 6.26e-04 | 189 | 125 | 6 | 2832_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 6.26e-04 | 189 | 125 | 6 | 4304_UP | |
| Drug | Propantheline bromide [50-34-0]; Down 200; 9uM; MCF7; HT_HG-U133A | 6.44e-04 | 190 | 125 | 6 | 3352_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 6.44e-04 | 190 | 125 | 6 | 4307_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 6.61e-04 | 191 | 125 | 6 | 2634_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 6.61e-04 | 191 | 125 | 6 | 4283_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; PC3; HT_HG-U133A | 6.61e-04 | 191 | 125 | 6 | 3811_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 6.61e-04 | 191 | 125 | 6 | 3605_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 6.61e-04 | 191 | 125 | 6 | 4647_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 6.61e-04 | 191 | 125 | 6 | 3926_DN | |
| Drug | rosiglitazone maleate; Up 200; 10uM; PC3; HG-U133A | 6.61e-04 | 191 | 125 | 6 | 430_UP | |
| Drug | Fenbendazole [43210-67-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 6.61e-04 | 191 | 125 | 6 | 3888_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A | 6.80e-04 | 192 | 125 | 6 | 4462_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 6.80e-04 | 192 | 125 | 6 | 5206_DN | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.80e-04 | 192 | 125 | 6 | 4108_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; PC3; HT_HG-U133A | 6.80e-04 | 192 | 125 | 6 | 4487_DN | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.80e-04 | 192 | 125 | 6 | 6573_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 6.99e-04 | 193 | 125 | 6 | 4173_DN | |
| Drug | 5114445; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 6.99e-04 | 193 | 125 | 6 | 901_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; PC3; HT_HG-U133A | 6.99e-04 | 193 | 125 | 6 | 5050_DN | |
| Disease | prostate carcinoma | COL6A3 SP3 SALL3 TRIO ZNF652 PPP1R13B RNF213 MAST2 TFAP4 SPDL1 MIPOL1 FOXP4 FOXP1 ZFHX3 QSER1 PLEKHH2 BSN PHIP | 2.22e-08 | 891 | 120 | 18 | EFO_0001663 |
| Disease | specific developmental disorder (implicated_via_orthology) | 2.62e-07 | 4 | 120 | 3 | DOID:0060038 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | COL6A3 NCKAP1 RNF213 MAST2 FASN ZFHX4 FOXP1 ZFHX3 MCF2L CMAHP NFAT5 PALLD HCFC1 CCDC157 NDRG4 NIN | 1.68e-04 | 1392 | 120 | 16 | EFO_0005763 |
| Disease | Abnormal corpus callosum morphology | 2.43e-04 | 6 | 120 | 2 | C1842581 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 3.40e-04 | 7 | 120 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | forced expiratory volume | SYNE1 SPTBN2 CNTLN ZBTB24 DST TULP4 FOXP1 CMAHP NFAT5 MN1 PHIP | 3.85e-04 | 789 | 120 | 11 | EFO_0004314 |
| Disease | right ventricular systolic volume measurement | 3.90e-04 | 35 | 120 | 3 | EFO_0021815 | |
| Disease | mean reticulocyte volume | SP3 PGS1 ZNF652 ITSN1 TFAP4 MIPOL1 TMCC2 FOXP1 TRAF3IP3 MN1 GOLGB1 | 4.28e-04 | 799 | 120 | 11 | EFO_0010701 |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 4.52e-04 | 8 | 120 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 5.75e-04 | 93 | 120 | 4 | C1535926 | |
| Disease | risky sexual behaviour measurement | 6.51e-04 | 169 | 120 | 5 | EFO_0007877 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 8.81e-04 | 11 | 120 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | mean platelet volume | MYO5A NUMA1 RSPH6A TFAP4 GCC2 TMCC2 PLEC MCF2L CMAHP PHIP GP5 NIN | 9.38e-04 | 1020 | 120 | 12 | EFO_0004584 |
| Disease | red blood cell density measurement | SP3 ITSN1 MAST2 ATP8B2 MIPOL1 DST SALL1 FOXP1 TRAF3IP3 PLEC CROCC | 9.46e-04 | 880 | 120 | 11 | EFO_0007978 |
| Disease | C-reactive protein measurement | RPGRIP1 SP3 PGS1 OLFML2B ATP8B2 SCAF4 SALL1 TMCC2 FOXP1 QSER1 BSN NFAT5 PMF1 | 1.27e-03 | 1206 | 120 | 13 | EFO_0004458 |
| Disease | hepatoblastoma (is_marker_for) | 1.66e-03 | 15 | 120 | 2 | DOID:687 (is_marker_for) | |
| Disease | lysophosphatidylcholine measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0010224 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.14e-03 | 17 | 120 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Intellectual Disability | 2.40e-03 | 447 | 120 | 7 | C3714756 | |
| Disease | inflammatory bowel disease | 2.46e-03 | 449 | 120 | 7 | EFO_0003767 | |
| Disease | bipolar disorder | 2.53e-03 | 577 | 120 | 8 | MONDO_0004985 | |
| Disease | response to ketamine | 2.83e-03 | 69 | 120 | 3 | EFO_0009748 | |
| Disease | anorexia nervosa | 2.94e-03 | 70 | 120 | 3 | MONDO_0005351 | |
| Disease | juvenile idiopathic arthritis | 3.45e-03 | 74 | 120 | 3 | EFO_0002609 | |
| Disease | platelet-to-lymphocyte ratio | 3.75e-03 | 363 | 120 | 6 | EFO_0008446 | |
| Disease | osteoarthritis, knee | 4.02e-03 | 158 | 120 | 4 | EFO_0004616 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERIISLQQQNSVLQN | 986 | Q9NXG0 | |
| FLQDISRQNSNNQQI | 211 | Q96DY2 | |
| ALETVQNNLSQTQQQ | 691 | Q4UJ75 | |
| SPLQANNQQQVIRVN | 281 | Q969M2 | |
| NALANNVLQLLDIQA | 66 | Q8IZP0 | |
| LQDAQQQLESLQQEA | 326 | Q9BSW2 | |
| QQLEEQVQQLEAQVQ | 396 | Q569K6 | |
| EQGQCQLRAQQELLQ | 491 | Q569K6 | |
| SLQLEQQQVDLQRLQ | 336 | Q5JU67 | |
| QQQVDLQRLQQELAN | 341 | Q5JU67 | |
| LYQELQIRNQLNQEQ | 271 | Q96KQ4 | |
| SRQQQQIEAQQQLLA | 136 | Q13625 | |
| QVDNNNRLLLQQVSL | 1291 | P01023 | |
| DNQVNNRQSQVLING | 126 | P98198 | |
| NRQSQVLINGILQQE | 131 | P98198 | |
| QLNQQIGQVNNAATL | 641 | Q2KHR3 | |
| LQQAARGQDRQQQLQ | 661 | A6NNM3 | |
| LQQAARGQDRQQQLQ | 661 | A6NJZ7 | |
| QQQLFQRTNALTVQQ | 261 | Q8TB72 | |
| GELQVIELNLNQNQI | 151 | Q8N9N7 | |
| IELNLNQNQISQISV | 156 | Q8N9N7 | |
| NQAAQQLLEIVQNQR | 191 | Q9H2P9 | |
| LTQQELAALVQQQQL | 1686 | P51610 | |
| LAALVQQQQLQEAQA | 1691 | P51610 | |
| QIQAQISALEEQLQQ | 406 | P13645 | |
| ENLTILAVQQNQLQQ | 146 | Q9HBL6 | |
| LAVQQNQLQQLDRAL | 151 | Q9HBL6 | |
| QREGLLTSLQNQVNQ | 1481 | Q86YW9 | |
| AQQLLQLQVFQLQQE | 386 | Q9BRK4 | |
| QVQQLISNLEAQLLQ | 386 | Q99456 | |
| HLQQQQQQLLQEETL | 56 | Q9UGP4 | |
| FLTAQQLQQLQQQGQ | 1241 | Q6P4R8 | |
| QQQNEELATQLQQAL | 381 | Q8TD10 | |
| LNTQRQQVQILLQEF | 4661 | Q03001 | |
| AISQFQQEIQQRQNE | 196 | Q5T655 | |
| LNNIIESQQQLLETQ | 26 | Q5JU85 | |
| VLQQQQEERQAQFAL | 2426 | Q9UPA5 | |
| QQALTQARLQQQSQP | 3791 | Q9UPA5 | |
| RTQTLDQENQQLQDQ | 156 | Q9BW19 | |
| QLETQNNNLQAQILA | 1071 | Q3V6T2 | |
| NNNLQAQILALQRQT | 1076 | Q3V6T2 | |
| QIAIVTENQALQQQL | 501 | Q32NB8 | |
| LNNLNLTQVQQRNLI | 206 | Q5KU26 | |
| QALQAARQLLLQQQT | 56 | O15409 | |
| QQQQQALQVARQLLL | 56 | Q9H334 | |
| ALQVARQLLLQQQQQ | 61 | Q9H334 | |
| RQVEELQLQVQAQQQ | 171 | Q6P1K2 | |
| ILPQNIQDQNQDLNL | 386 | Q8IV20 | |
| QLVQQEAAQQQQALA | 1031 | Q86UK5 | |
| TVTQLQQLLQAVNQQ | 1331 | Q86UP2 | |
| LNNENKSTLQLEQQV | 476 | A6NEF3 | |
| VCLVENNNEQLLVNQ | 11 | Q6ZN66 | |
| QQQALQVARQFLLQQ | 66 | Q8IVH2 | |
| NVCNNQEQLLEALRQ | 756 | P0C869 | |
| LLQTQLVDQLQQQEA | 641 | Q08379 | |
| TQERLEAATQQNQQL | 671 | Q08379 | |
| EAATQQNQQLRAQLS | 676 | Q08379 | |
| SRREPQVNQQQLQQL | 1311 | Q7Z6Z7 | |
| QQQSPLQEQAQTLQQ | 741 | O94916 | |
| LELENQNLRLINQNQ | 141 | Q8IVE3 | |
| AVETRNNNQQLAQLQ | 66 | Q9Y2A7 | |
| PEQQQQQLQSLREQV | 111 | Q9NWA0 | |
| LSQPIQIAQDLQQLQ | 166 | P14859 | |
| NANLDIQNVNQQTAL | 656 | Q86YT6 | |
| QQLQNQIRLEQEAGA | 661 | Q8WX93 | |
| AQLEVDAQQQQLELQ | 1941 | Q5TZA2 | |
| LETFQNNNALLDQIQ | 1161 | Q9C0G6 | |
| VQAEQQARLQAVQQQ | 1001 | Q8TES7 | |
| VRVNQNNLQAQVIVD | 151 | Q7L8L6 | |
| LQNNTILRLLQQVSQ | 431 | Q14152 | |
| QEAFVQQSQNELQQI | 236 | H7C350 | |
| QNQNTIQELLQNCSD | 66 | P15924 | |
| QILNDQLKQVQQNSL | 546 | Q15811 | |
| QEDRQLINALQINNT | 2546 | P12111 | |
| DQELEALQQEQQQAQ | 1816 | Q9BV73 | |
| QDSQNNLQINVSELQ | 1366 | Q8IWJ2 | |
| AQESQAQAILQQARL | 541 | P20908 | |
| QNIQEDDLQQLQLFT | 176 | Q6DD88 | |
| RANLQNLLVVNQNSA | 56 | Q3C1V0 | |
| VNQDQLDNQATVQRL | 311 | O15068 | |
| QNLILRNQIQQAFVE | 546 | Q6P0Q8 | |
| QNLILRNQIQQVFVE | 401 | O60307 | |
| VNLQELALNQNQLDF | 146 | P40197 | |
| QAQAQGITLTLQQAQ | 1091 | A6NE01 | |
| LNNENKSTLQLEQQV | 376 | I6L899 | |
| AQQQTQLNLRSLLVN | 2211 | P49327 | |
| LSDIQQAIRLQQQQQ | 196 | Q9NZ56 | |
| QQQQQQQQRSEELLA | 96 | Q6NYC8 | |
| QLFQTTQGQQLQQIL | 191 | O95104 | |
| EQLLALQQQQIHQLQ | 231 | Q9NSC2 | |
| ALQQQQIHQLQLIEQ | 211 | Q9BXA9 | |
| FQQAQAQAVLQQTQL | 461 | P25940 | |
| RSDLSLIQQQQQQQQ | 36 | Q6P995 | |
| AQTLQQQEQASQGLR | 536 | Q14980 | |
| AQRLQAQLNELQAQL | 1586 | Q14980 | |
| QQNQELQEQLRSLEQ | 1626 | Q14980 | |
| LQAQIQLQRQQFSIS | 1156 | Q10571 | |
| LALQQQLQAVRQALT | 246 | Q9P0W2 | |
| QRLQQGQSSLFQQLD | 121 | Q9H0K4 | |
| LIAEQLQQQVSQLQD | 401 | Q96KN7 | |
| LQQQVSQLQDQLDAE | 406 | Q96KN7 | |
| LQQQQQQVVQLEGVE | 621 | O75069 | |
| VQVQVDNLQNLQDDL | 7166 | Q8NF91 | |
| NLQNISLQNNRLRQL | 366 | Q8TF66 | |
| SQNQEKLQELNQRLT | 1601 | Q8N4C6 | |
| LQQAARGQDRQQQLQ | 661 | Q9UFD9 | |
| VANQDLQVQLDQALQ | 231 | Q96EA4 | |
| RVTLQNQLQQFLEAQ | 536 | Q9Y6H5 | |
| QLCLLQEVQQQLNSD | 161 | Q9UIF3 | |
| RQQIGNVVNQANLQL | 186 | Q9ULP0 | |
| ALQAVEATQGQQQQL | 616 | O95785 | |
| LRNLIATAQAQNQQQ | 76 | O94864 | |
| QNEADNQENVLSQLL | 46 | Q68BL8 | |
| QQAGQQEQLLRQLQD | 1416 | Q9NRC6 | |
| NLNQSGVQLTNINVV | 126 | Q9Y471 | |
| DDQLNQLFNLLQQTV | 536 | P63136 | |
| SEEQQLLLQVQQQHQ | 61 | P52655 | |
| LNTQDVQDVQNVQNI | 806 | Q63HN8 | |
| TRVQQLQGLLQNQSL | 411 | Q9Y228 | |
| QSLLANQNVQLDVLT | 711 | Q9NRJ4 | |
| DQQQNLTEQFLNRSI | 466 | O94967 | |
| TQLQILQQQAQQYQA | 1746 | Q86UP3 | |
| RQQLNVRNVANNILA | 296 | Q99973 | |
| SGLNQVLSQQANQEI | 626 | Q8WWQ0 | |
| RQLANSLSGVQNQLQ | 331 | O15020 | |
| VQNLQNLQIQNTAAQ | 471 | Q02447 | |
| QLQEDQENNLQDNQT | 1596 | Q92576 | |
| QQQQQVVQLEGLENA | 566 | O94876 | |
| RNLQEQLQLANQEKT | 131 | Q96NL6 | |
| VQQEQLLQETQALQQ | 2616 | Q15149 | |
| QDQRQTEAIQLLQAQ | 971 | Q9UBS9 | |
| NENITNQGNQIVSLI | 206 | Q8NAM6 | |
| QLQNLILSAQQEQTE | 601 | O43167 | |
| DDQLNQLFNLLQQTV | 541 | Q9WJR5 | |
| QIIVEVNLNNQTLNV | 116 | Q9Y2D9 | |
| AAAQLVRNLVNAQQV | 1386 | Q5TAX3 | |
| LEQAISQRIQTNNNP | 126 | Q04206 | |
| QLQQQQEQVRLLHQE | 196 | Q01664 | |
| EARLGALQQLQQQSQ | 251 | Q13488 | |
| ALQQLQQQSQELQEV | 256 | Q13488 | |
| INQILENQRNFLNAL | 2266 | O75962 | |
| LQQELQQQAALIQSQ | 1756 | Q15911 | |
| SAQTIQQLEDQLQQK | 416 | Q14789 | |
| NENIGDQLRQLQIQV | 1226 | Q14789 | |
| SRTLLSPQQQQQQQV | 3981 | O14686 | |
| QETAANLQNQINTLE | 711 | Q9C099 | |
| EENNRQQQLLAQNLQ | 1376 | Q9Y4I1 | |
| QLQEELQNKSQQLRA | 406 | Q5VU43 | |
| SIQGNNCLRLQLQQQ | 2061 | Q5VU43 |